$15.56 +0.50 (%) Biocryst Pharmaceuticals Inc - NASDAQ

Jul. 28, 2015 | 12:40 PM

Partner Headlines

  1. 6 Movers To Keep An Eye On Next Week

    Benzinga | Jul. 18, 2015 | 10:18AM EST
  2. FedBizOpps Reporting Biocryst Received $12,133,606 For BCX4430 NDA Enabling CMC and Non-Clinical Toxicology Studies

    Benzinga | Jul. 2, 2015 | 13:34PM EST
  3. Benzinga's Top Upgrades

    Benzinga | Jun. 30, 2015 | 09:50AM EST
  4. Sierra Leone's Freetown Set Back In Ebola Eradication

    Benzinga | Jun. 23, 2015 | 07:04AM EST
  5. Tekmira falls on Ebola news

    IBD | Jun. 19, 2015 | 18:50PM EST
  6. Tekmira Tumbles On Ominous Signs For Ebola Drug

    IBD | Jun. 19, 2015 | 12:49PM EST
  7. An Ebola-Fighting Portfolio For The Present...And The Future

    Benzinga | Jun. 19, 2015 | 10:04AM EST
  8. US Stock Futures Rise Ahead Of Economic Data

    Benzinga | May. 13, 2015 | 07:49AM EST
  9. BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX7353 for the Treatment of Hereditary Angioedema

    Benzinga | May. 13, 2015 | 06:58AM EST
  10. Benzinga's Top Initiations

    Benzinga | Apr. 21, 2015 | 09:36AM EST
  11. Benzinga's Top Upgrades

    Benzinga | Apr. 20, 2015 | 10:09AM EST
  12. UPDATE: BioCryst Pharmaceuticals Posts Narrower-Than-Expected Q4 Loss

    Benzinga | Feb. 18, 2015 | 08:54AM EST
  13. Benzinga's Top #PreMarket Gainers

    Benzinga | Jan. 14, 2015 | 08:06AM EST
  14. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 3

    Benzinga | Jan. 13, 2015 | 10:58AM EST
  15. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD | Dec. 26, 2014 | 16:09PM EST
  16. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga | Dec. 23, 2014 | 07:08AM EST
  17. BioCryst Pharmaceuticals'

    IBD | Dec. 22, 2014 | 18:28PM EST
  18. Monday's #PreMarket Movers: Caesars, Enta, Twitter And More

    Benzinga | Dec. 22, 2014 | 09:06AM EST
  19. Benzinga's Top #PreMarket Gainers

    Benzinga | Dec. 22, 2014 | 08:09AM EST
  20. US Stock Futures Signal Higher Start On Wall Street

    Benzinga | Dec. 18, 2014 | 07:35AM EST
  21. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga | Dec. 11, 2014 | 14:14PM EST
  22. UPDATE: Bank Of America Reiterates On BioCryst Pharmaceuticals Following EU Physicians Survey

    Benzinga | Dec. 4, 2014 | 10:27AM EST
  23. Ebola Vaccine Contenders

    Benzinga | Oct. 30, 2014 | 10:44AM EST
  24. Making Money With Charles Payne: 10/24/14

    FoxBusiness | Oct. 24, 2014 | 18:00PM EST
  25. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness | Oct. 17, 2014 | 14:52PM EST
  26. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga | Oct. 17, 2014 | 10:58AM EST
  27. Making Money With Charles Payne: 10/16/14

    FoxBusiness | Oct. 16, 2014 | 18:00PM EST
  28. Making Money With Charles Payne: 10/08/14

    FoxBusiness | Oct. 8, 2014 | 18:00PM EST
  29. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga | Oct. 8, 2014 | 13:04PM EST
  30. US Stock Futures Edge Higher Ahead Of Alcoa Earnings, Fed Minutes

    Benzinga | Oct. 8, 2014 | 07:19AM EST
  31. Making Money With Charles Payne: 10/07/14

    FoxBusiness | Oct. 7, 2014 | 18:00PM EST
  32. Benzinga's Top #PreMarket Gainers

    Benzinga | Oct. 7, 2014 | 08:10AM EST
  33. BioCryst Reports Late Breaker Presentation of OPuS-1 Phase 2 Trial Results

    Benzinga | Oct. 7, 2014 | 07:10AM EST
  34. Making Money With Charles Payne: 10/0614

    FoxBusiness | Oct. 6, 2014 | 18:00PM EST
  35. Chimerix Ebola Drug OK'd; Tekmira Drops On Downgrade

    IBD | Oct. 6, 2014 | 14:31PM EST
  36. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga | Oct. 6, 2014 | 14:08PM EST
  37. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement Of Acquisition By Becton, Dickinson

    Benzinga | Oct. 6, 2014 | 14:00PM EST
  38. Markets Open Higher; Hewlett-Packard Plans To Split Into Two Companies

    Benzinga | Oct. 6, 2014 | 10:58AM EST
  39. Jobs Data Boost Stock Futures; Salix, Tekmira, Iamgold Rising

    IBD | Oct. 3, 2014 | 09:02AM EST
  40. Making Money With Charles Payne: 10/01/14

    FoxBusiness | Oct. 1, 2014 | 18:00PM EST
  41. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD | Oct. 1, 2014 | 14:20PM EST
  42. Morning Market Movers

    Benzinga | Oct. 1, 2014 | 09:39AM EST
  43. Making Money With Charles Payne: 09/30/14

    FoxBusiness | Oct. 1, 2014 | 06:18AM EST
  44. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat Results

    Benzinga | Sep. 24, 2014 | 15:54PM EST
  45. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga | Sep. 24, 2014 | 13:17PM EST
  46. BioCryst Receives Additional NIAID Funding For Manufacture and Development Of BCX4430, $19.9M Has Been Awarded To Date Under The Contract

    Benzinga | Sep. 18, 2014 | 12:08PM EST
  47. Momentum Stocks Showing Weakness

    Benzinga | Sep. 15, 2014 | 17:33PM EST
  48. BioCryst Announces RAPIVAB Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting

    Benzinga | Sep. 6, 2014 | 11:23AM EST
  49. BioCryst Pharmaceuticals, Inc. Sinks; WHO Notes Ebola Safety Data Unavailable

    Benzinga | Sep. 5, 2014 | 13:18PM EST
  50. BioCryst To Present Peramivir Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting

    Benzinga | Sep. 2, 2014 | 06:53AM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!